Natalie Hug joined Maxia Strategies in Spring 2023. Prior to that, Natalie has spent the past several years as a regulatory consultant in Zürich, with particular focus on regulatory submissions to Swissmedic and supporting Swiss market access activities. She holds a MSc in molecular biology from the University of Basel and speaks German, French and English.
At Maxia Strategies, Natalie provides global and European regulatory support across all phases of development. She also serves as a principal liaison with Swissmedic, supporting clients with obtaining and maintaining product licenses in Switzerland and managing ACCESS Consortium activities.